Protein Z, a protein seeking a pathology

Summary

Protein Z (PZ) is a vitamin K-dependent factor identified in human plasma in 1984 characterized by an homology with other vitamin K-dependent factors (factor VII, IX, X, protein C). In contrast to these factors, PZ does not possess any enzymatic activity but is involved as a cofactor in the down-regulation of coagulation by forming a complex with the protein Z-dependent protease inhibitor (ZPI). ZPI inhibits the activated factor X (FXa) on phospholipid surface. In mice, the disruption of PZ gene is asymptomatic, but the association with the factor V Leiden mutation leads to a quasi complete mortality during the neonatal period with microvascular thrombosis. In humans, PZ is characterized by an unusual wide distribution in plasma, and a major decrease induced by warfarin. Isolated PZ deficiency does not seem to constitute a risk for venous thrombosis, but a severe PZ deficiency could increase the risk of well recognized venous thrombotic risk factors such as factor V Leiden, G20210A mutation or hyperhomocysteinemia. Unexpectedly, a relationship between PZ deficiency and ischemic arterial diseases such as stroke, acute coronary syndromes or peripheral arterial disease was described but not confirmed by all studies. PZ deficiency could be also a risk factor for early fetal losses, and increases the arterial risk in antiphospholipid syndrome. This review analyzes the different studies so far published and discusses the various results obtained in order to understand whether or not protein Z deficiency could be considered as an arterial ischemic risk factor.

Keywords

Vitamin K-dependent factors - arterial thrombosis - coagulation inhibitors - pregnancy

• References

• 1 Rau JC, Beaulieu LM, Huntington JA. et al. Serpins in thrombosis, hemostasis and fibrinolysis. J Thromb Haemost 2007; 05: 102-115.
• 2 Han X, Fiehler R, Broze Jr. GJ. Isolation of a protein Z-dependent plasma protease inhibitor. Proc Natl Acad Sci USA 1998; 95: 9250-9255.
• 3 Han X, Huang ZF, Fiehler R. et al. The protein Z-dependent protease inhibitor is a serpin. Biochemistry 1999; 38: 11073-11078.
• 4 Han X, Fiehler R, Broze Jr. GJ. Characterization of the protein Z-dependent protease inhibitor. Blood 2000; 96: 3049-3055.
• 5 Prowse CV, Esnouf MP. The isolation of a new warfarin-sensitive protein from bovine plasma. Biochem Soc Trans 1977; 05: 255-256.
• 6 Broze Jr. GJ, Miletich JP. Human protein Z. J Clin Invest 1984; 73: 933-938.
• 7 Petersen TE, Thlgersen HC, Sottrup-Jensen L. et al. Isolation and N-terminal amino acid sequence of protein Z, a gamma-carboxyglutamic acid containing protein from bovine plasma. FEBS Lett 1980; 114: 278-282.
• 8 Højrup P, Roepstorff P, Petersen TE. Amino-acid sequence of the vitamin-K-dependent part of protein Z. Eur J Biochem 1982; 126: 343-348.
• 9 Broze Jr. GJ. Protein Z-dependent regulation of coagulation. Thromb Haemost 2001; 86: 8-13.
• 10 Højrup P, Jensen MS, Petersen TE. Amino acid sequence of bovine protein Z: a vitamin K-dependent serine protease homolog. FEBS Lett 1985; 184: 333-338.
• 11 Persson E, Stenflo J. Comparison of the Ca²⁺ binding properties of the gamma-carboxyglutamic acid-containing module of protein Z in the intact protein and in N-terminal fragments. FEBS Lett 1992; 314: 5-9.
• 12 Fernlund P, Stenflo J. Beta-hydroxyaspartic acid in vitamin K-dependent proteins. J Biol Chem 1983; 258: 12509-1212.
• 13 Nishimura H, Kawabata S, Kisiel W. et al. Identification of a disaccharide (Xyl-Glc) and a trisaccharide (Xyl2-Glc) O-glycosidically linked to a serine residue in the first epidermal growth factor-like domain of human factors VII and IX and protein Z and bovine protein Z. J Biol Chem 1989; 264: 20320-20325.
• 14 Handford PA, Baron M, Mayhew M. et al. The first EGF-like domain from human factor IX contains a high-affinity calcium binding site. EMBO J 1990; 09: 475-480.
• 15 Morita T, Kaetsu H, Mizuguchi J. et al. A characteristic property of vitamin K-dependent plasma protein Z. J Biochem 1988; 104: 368-374.
• 16 McDonald JF, Shah AM, Schwalbe RA. et al. Comparison of naturally occurring vitamin K-dependent proteins: correlation of amino acid sequences and membrane binding properties suggests a membrane contact site. Biochemistry 1997; 36: 5120-5127.
• 17 Miletich JP, Broze Jr. GJ. Human plasma protein Z antigen: range in normal subjects and effect of warfarine therapy. Blood 1987; 69: 1580-1586.
• 18 Sejima H, Hayashi T, Deyashiki Y. et al. Primary structure of vitamin K-dependent human protein Z. Biochem Biophys Res Commun 1990; 171: 661-668.
• 19 Ichinose A, Takeya H, Espling E. et al. Amino acid sequence of human protein Z, a vitamin K-dependent plasma glycoprotein. Biochem Biophys Res Commun 1990; 172: 1139-1144.
• 20 Iwanaga S, Nishimura H, Kawabata S. et al. A new trisaccharide sugar chain linked to a serine residue in the first EGF-like domain of clotting factors VII and IX and protein Z. Adv Exp Med Biol 1990; 281: 121-131.
• 21 Hogg PJ, Stenflo J. Interaction of vitamin K-dependent protein Z with thrombin. Consequences for the amidolytic activity of thrombin and the interaction of thrombin with phospholipids vesicles. J Biol Chem 1991; 266: 10953-10958.
• 22 Hogg PJ, Stenflo J. Interaction of human protein Z with thrombin: evaluation of the species difference in the interaction between bovine and human protein Z and thrombin. Biochem Biophys Res Commun 1991; 178: 801-807.
• 23 Lee CJ, Chandrasekaran V, Duke RE. et al. A proposed structural model of human protein Z. J Thromb Haemost 2007; 05: 1558-1561.
• 24 Souri M, Koseki-Kuno S, Iwata H. et al. A naturally occurring E30Q mutation in the Gla domain of protein Z causes its impaired secretion and subsequent deficiency. Blood 2005; 105: 3149-3154.
• 25 Rice GI, Futers TS, Grant PJ. Identification of novel polymorphisms within the protein Z gene, haplotype distribution and linkage analysis. Thromb Haemost 2001; 85: 1123-1124.
• 26 Kemkes-Matthes B, Matthes KJ, Souri M. et al. R255h amino acid substitution of protein Z identified in patients with factor V Leiden mutation. Br J Haematol 2005; 128: 248-252.
• 27 Kemkes-Matthes B, Matthes KJ. Protein Z, a new haemostatic factor, in liver diseases. Haemostasis 1995; 25: 312-316.
• 28 Vasse M, Denoyelle C, Corbière C. et al. Human endothelial cells synthesize protein Z, but not the protein Z dependent inhibitor. Thromb Haemost 2006; 95: 519-523.
• 29 Fujimaki K, Yamazaki T, Taniwaki M. et al. The gene for human protein Z is localized to chromosome 13 at band q34 and is coded by eight regular exons and one alternative exon. Biochemistry 1998; 37: 6838-6846.
• 30 Sugawara H, Iwata H, Souri M. et al. Regulation of human protein Z gene expression by liver-enriched transcription factor HNF-4alpha and ubiquitous factor Sp1. J Thromb Haemost 2007; 05: 2250-2258.
• 31 Santacroce R, Cappucci F, Di Perna P. et al. Protein Z gene polymorphisms are associated with protein Z plasma levels. J Thromb Haemost 2004; 02: 1197-1199.
• 32 Santacroce R, Sarno M, Cappucci F. et al. Low protein Z levels and risk of occurrence of deep vein thrombosis. J Thromb Haemost 2006; 04: 2417-2422.
• 33 Lichy C, Kropp S, Dong-Si T. et al. A common polymorphism of the protein Z gene is associated with protein Z plasma levels and with risk of cerebral ischemia in the young. Stroke 2004; 35: 40-45.
• 34 Staton J, Sayer M, Hankey GJ. et al. Protein Z gene polymorphisms, protein Z concentrations, and ischemic stroke. Stroke 2005; 36: 1123-1127.
• 35 Iwata H, Souri M, Kemkes-Matthes B. et al. An additional Glu30Lys substitution in the Gla domain of the protein Z gene is not a common polymorphism but a rare mutation, which would cause its deficiency. J Thromb Haemost 2005; 03: 2360-2361.
• 36 Yin Z-F, Huang ZF, Cui J. et al. Prothrombotic phenotype of protein Z deficiency. Proc Natl Acad Sci USA 2000; 97: 6734-6738.
• 37 Tabatabai A, Fiehler R, Broze Jr. GJ. Protein Z circulates in plasma in a complex with protein Z-dependent protease inhibitor. Thromb Haemost 2001; 85: 655-660.
• 38 McQuillan AM, Eikelboom JW, Hankey GJ. et al. Protein Z in ischemic stroke and its etiologic subtypes. Stroke 2003; 34: 2415-2419.
• 39 Steffano B, Forastiero R, Martinuzzo M. et al. Low plasma protein Z levels in patients with antiphospholipid antibodies. Blood Coagul Fibrinolysis 2001; 12: 411-412.
• 40 Heeb MJ, Paganini-Hill A, Griffin JH. et al. Low protein Z levels and risk of ischemic stroke: differences by diabetic status and gender. Blood Cells Mol Dis 2002; 29: 139-144.
• 41 Refaai MA, Ahn C, Lu L. et al. Protein Z and ZPI levels and cardiovascular events. J Thromb Haemost 2006; 04: 1628-1629.
• 42 Heeb MJ, Fisher M, Paganini-Hill A. Association of low protein Z levels with ischemic stroke in young women. Thromb Haemost 2007; 97: 495-496.
• 43 Ravi S, Mauron T, Lämmle B. et al. Protein Z in healthy human individuals and in patients with a bleeding tendency. Br J Haematol 1998; 102: 1219-1223.
• 44 Fedi S, Sofi F, Brogi D. et al. Low protein Z plasma levels are independently associated with acute coronary syndromes. Thromb Haemost 2003; 90: 1173-1178.
• 45 Yurdakök M, Gürakan B, Ozbag E. et al. Plasma protein Z levels in healthy newborn infants. Am J Hematol 1995; 48: 206-207.
• 46 Schettini Jr. F, Laforgia N, Altomare M. et al. Plasma protein Z levels in healthy and high-risk newborn infants. Acta Paediatr 2004; 93: 654-657.
• 47 Yurdakök M, Yigit S, Aygön C. et al. Plasma protein Z levels in early respiratory distress syndrome. Am J Hematol 1997; 54: 171-172.
• 48 Quack Loetscher KC, Stiller R, Roos M. et al. Protein Z in normal pregnancy. Thromb Haemost 2005; 93: 706-709.
• 49 Ramsay JE, Stewart F, Friel H. et al. Protein Z in pregnancy: exaggerated rise in obese women. J Thromb Haemost 2005; 03: 2584-2586.
• 50 Paidas MJ, Ku DH, Lee MJ. et al. Protein Z, protein S levels are lower in patients with thrombophilia and subsequent pregnancy complications. J Thromb Haemost 2005; 03: 497-501.
• 51 Bretelle F, Arnoux D, Shojai R. et al. Protein Z in patients with pregnancy complications. Am J Obstet Gynecol 2005; 193: 1698-1702.
• 52 Kusanovic JP, Espinoza J, Romero R. et al. Plasma protein Z concentrations in pregnant women with idiopathic intrauterine bleeding and in women with spontaneous preterm labor. J Matern Fetal Neonatal Med 2007; 20: 453-463.
• 53 Al-Shanqeeti A, van Hylckama Vlieg A, Berntorp E. et al. Protein Z and protein Z-dependent protease inhibitor. Determinants of levels and risk of venous thrombosis. Thromb Haemost 2005; 93: 411-413.
• 54 Undar L, Karadogan I, Oztürk F. Plasma protein Z levels inversely correlate with plasma interleukin-6 levels in patients with acute leukemia and non-Hodgkin’s lymphoma. Thromb Res 1999; 94: 131-134.
• 55 Vasse M, Denoyelle C, Legrand E. et al. Weak regulation of protein Z biosynthesis by inflammatory cytokines. Thromb Haemost 2002; 87: 350-351.
• 56 Cesari F, Gori AM, Fedi S. et al. Modifications of protein Z and interleukin-6 during the acute phase of coronary artery disease. Blood Coagul Fibrinolysis 2007; 18: 85-86.
• 57 Ozkaya O, Bek K, Fisgin T. et al. Low protein Z levels in children with nephrotic syndrome. Pediatr Nephrol 2006; 21: 1122-1126.
• 58 Malyszko J, Skrzydlewska E, Malyszko JS. et al. Protein Z, a vitamin K-dependent protein in patients with renal failure. J Thromb Haemost 2003; 01: 195-196.
• 59 Blyth E, Favaloro EJ, Harris D. et al. Protein Z is reduced in chronic kidney disease and not elevated in patients on haemodialysis. Blood Coagul Fibrinolysis 2008; 19: 23-25.
• 60 Usalan C, Erdem Y, Altun B. et al. Protein Z levels in haemodialysis patients. Int Urol Nephrol 1999; 31: 541-545.
• 61 Bek K, Ozkaya O, Fişgin T. et al. Protein Z and natural anticoagulants in children on peritoneal dialysis and hemodialysis. Pediatr Nephrol 2007; 22: 881-886.
• 62 Del Vecchio GC, Nigro A, Giordano P. et al. Plasma protein Z and protein C inhibitors and their role in hypercoagulability of thalassemia. Acta Haematol 2007; 118: 136-140.
• 63 Shang Y, Pan XY, Ding CP. et al. Clinical significance of protein Z detection in patients with malignant tumors. Ai Zheng 2005; 24: 1144-1147.
• 64 Kemkes-Matthes B, Matthes KJ. Protein Z deficiency: a new cause of bleeding tendency. Thromb Res 1995; 79: 49-55.
• 65 Gamba G, Bertolino G, Montani N. et al. Bleeding tendency of unknown origin and protein Z levels. Thromb Res 1998; 90: 291-295.
• 66 Obach V, Muñoz X, Sala N. et al. Intronic c.573 + 79G>A polymorphism of protein Z gene in haemorrhagic and ischaemic stroke. Thromb Haemost 2006; 95: 1040-1041.
• 67 Dahlbäck B. Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis. Thromb Haemost 1997; 78: 483-488.
• 68 Vasse M, Guegan-Massardier E, Borg JY. et al. Frequency of protein Z deficiency in patients with ischaemic stroke. Lancet 2001; 357: 933-934.
• 69 Martinelli I, Razzari C, Biguzzi E. et al. Low levels of protein Z and the risk of venous thromboembolism. J Thromb Haemost 2005; 03: 2817-2819.
• 70 Kemkes-Matthes B, Nees M, Kühnel G. et al. Protein Z influences the prothrombotic phenotype in Factor V Leiden patients. Thromb Res 2002; 106: 183-185.
• 71 Ayoub N, Esposito G, Barete S. et al. Protein Z deficiency in antiphospholipid-negative Sneddon’s syndrome. Stroke 2004; 35: 1329-1332.
• 72 Lopaciuk S, Bykowska K, Kwiecinski H. et al. Protein Z in young survivors of ischemic stroke. Thromb Haemost 2002; 88: 536.
• 73 Kobelt K, Biasiutti FD, Mattle HP. et al. Protein Z in ischaemic stroke. Br J Haematol 2001; 114: 169-173.
• 74 Marco P, Marín F, García A. et al. Do protein Z levels influence the prothrombotic state in atrial fibrillation?. Thromb Res 2002; 106: 269-270.
• 75 Sofi F, Cesari F, Vigiani S. et al. Protein Z plasma levels in different phases of activity of coronary atherosclerosis. J Thromb Haemost 2005; 03: 2254-2258.
• 76 Sofi F, Cesari F, Marcucci R. et al. Protein Z levels and prognosis in patients with acute coronary syndromes. Clin Chem Lab Med 2006; 44: 1098-1102.
• 77 Cesari F, Fatini C, Sticchi E. et al. Protein Z gene polymorphisms (intron F 79 G>A; –13 A>G) are not associated with acute coronary syndromes. Thromb Haemost 2006; 96: 98-99.
• 78 Morange PE, Juhan-Vague I. PRIME Study Group. Protein Z plasma levels are not associated with the risk of coronary heart disease: the PRIME Study. J Thromb Haemost 2004; 02: 2050-2051.
• 79 Sofi F, Cesari F, Pratesi G. et al. Low protein Z levels in patients with peripheral arterial disease. Thromb Haemost 2007; 98: 1114-1117.
• 80 Pardos-Gea J, Ordi-Ros J, Serrano S. et al. Protein Z levels and anti-protein Z antibodies in patients with arterial and venous thrombosis. Thromb Res. 2007 doi:10.1016/j.thromres.2007.07.009.
• 81 Koren-Michowitz M, Eting E, Rahimi-Levene N. et al. Protein Z levels and central retinal vein or artery occlusion. Eur J Haematol 2005; 75: 401-405.
• 82 Oztürk MA, Ozbalkan Z, Onat AM. et al. Decreased protein Z concentrations complicating the hypercoagulable state of Behçet’s disease. Clin Appl Thromb Hemost 2003; 09: 259-263.
• 83 Koutroubakis IE, Theodoropoulou A, Sfiridaki A. et al. Low plasma protein Z levels in patients with ischemic colitis. Dig Dis Sci 2003; 48: 1673-1676.
• 84 McColl MD, Deans A, Maclean P. et al. Plasma protein Z deficiency is common in women with antiphospholipid antibodies. Br J Haematol 2003; 120: 913-914.
• 85 Forastiero RR, Martinuzzo ME, Lu L. et al. Autoimmune antiphospholipid antibodies impair the inhibition of activated factor X by protein Z/protein Z-dependent protease inhibitor. J Thromb Haemost 2003; 01: 1764-1770.
• 86 Gris JC, Amadio C, Mercier E. et al. Anti-protein Z antibodies in women with pathologic pregnancies. Blood 2003; 101: 4850-4852.
• 87 Sailer T, Vormittag R, Koder S. et al. Clinical significance of anti-protein Z antibodies in patients with lupus anticoagulant. Thromb Res. 2007 doi:10.1016/j.thromres.2007.07.014.
• 88 Gris JC, Quéré I, Dechaud H. et al. High frequency of protein Z deficiency in patients with unexplained early fetal loss. Blood 2002; 99: 2606-2608.
• 89 Gris JC, Mercier E, Quéré I. et al. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 2004; 103: 3695-3699.
• 90 Erez O, Hoppensteadt D, Romero R. et al. Preeclampsia is associated with low concentrations of protein Z. J Matern Fetal Neonatal Med 2007; 20: 661-667.
• 91 Grandone E, Colaizzo D, Cappucci F. et al. Protein Z levels and unexplained fetal losses. Fertil Steril 2004; 82: 982-983.
• 92 Dossenbach-Glaninger A, van Trotsenburg M, Helmer H. et al. Association of the protein Z intron F G79A gene polymorphism with recurrent pregnancy loss. Fertil Steril. 2008 doi:10.1016/fertnstert.2007.07.1376.
• 93 Greten J, Kreis I, Liliensiek B. et al. Localisation of protein Z in vascular lesions of patients with atherosclerosis. Vasa 1998; 27: 144-148.
• 94 Mallat Z, Besnard S, Duriez M. et al. Protective role of interleukin-10 in atherosclerosis. Circ Res 1999; 85: e17-24.
• 95 Uyemura K, Demer LL, Castle SC. et al. Cross-regulatory roles of interleukin (IL-)12 and IL-10 in atherosclerosis. J Clin Invest 1996; 97: 2130-2138.
• 96 Herbert J, Bono F, Herault J. et al. Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo. Clin Invest 1998; 101: 993-1000.
• 97 Ragosta M, Gimple LW, Gertz SD. et al. Specific factor Xa inhibition reduces restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Circulation 1994; 89: 1262-1271.
• 98 Frère C, Morange PE, Saut N. et al. Quantification of thrombin activatable fibrinolysis inhibitor (TAFI) gene polymorphism effects on plasma levels of TAFI measured with assays insensitive to isoform-dependent artefact. Thromb Haemost 2005; 94: 373-379.